This protocol covers eosinophilic granulomatosis with polyangiitis (EGPA) presenting without organ-threatening or life-threatening manifestations — whether at new onset or in relapse. Induction of remission is the primary treatment objective in this setting.
A glucocorticoid-based regimen is recommended for remission induction in this population. The full protocol defines the specific agents, structured dosing guidance, and tapering approach.
Achieve remission — defined as the absence of typical signs, symptoms, and other features of active disease.
For induction of remission in new-onset or relapsing EGPA without organ-threatening or life-threatening manifestations, we recommend treatment with glucocorticoids.
View source ↗